These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20920668)

  • 21. Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss?
    Zhang H; Zhou ZW; Sun L
    J Neurochem; 2021 May; 157(3):351-369. PubMed ID: 33236345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.
    Vester A; Velez-Ruiz G; McLaughlin HM; ; Lupski JR; Talbot K; Vance JM; Züchner S; Roda RH; Fischbeck KH; Biesecker LG; Nicholson G; Beg AA; Antonellis A
    Hum Mutat; 2013 Jan; 34(1):191-9. PubMed ID: 22930593
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Morant L; Erfurth ML; Jordanova A
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy.
    Scheidecker S; Bär S; Stoetzel C; Geoffroy V; Lannes B; Rinaldi B; Fischer F; Becker HD; Pelletier V; Pagan C; Acquaviva-Bourdain C; Kremer S; Mirande M; Tranchant C; Muller J; Friant S; Dollfus H
    Hum Mutat; 2019 Oct; 40(10):1826-1840. PubMed ID: 31116475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of aminoacyl-tRNA synthetases in genetic diseases.
    Antonellis A; Green ED
    Annu Rev Genomics Hum Genet; 2008; 9():87-107. PubMed ID: 18767960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies.
    Safka Brozkova D; Deconinck T; Griffin LB; Ferbert A; Haberlova J; Mazanec R; Lassuthova P; Roth C; Pilunthanakul T; Rautenstrauss B; Janecke AR; Zavadakova P; Chrast R; Rivolta C; Zuchner S; Antonellis A; Beg AA; De Jonghe P; Senderek J; Seeman P; Baets J
    Brain; 2015 Aug; 138(Pt 8):2161-72. PubMed ID: 26072516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.
    Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R
    J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy.
    Rhymes ER; Simkin RL; Qu J; Villarroel-Campos D; Surana S; Tong Y; Shapiro R; Burgess RW; Yang XL; Schiavo G; Sleigh JN
    Neurobiol Dis; 2024 Jun; 195():106501. PubMed ID: 38583640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
    Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F
    Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
    Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
    Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant aminoacyl-tRNA synthetase disorders: lessons learned from
    Kalotay E; Klugmann M; Housley GD; Fröhlich D
    Front Neurosci; 2023; 17():1182845. PubMed ID: 37274211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant
    Beijer D; Marte S; Li JC; De Ridder W; Chen JZ; Tadenev ALD; Miers KE; Deconinck T; Macdonell R; Marques W; De Jonghe P; Pratt SL; Meyer-Schuman R; Züchner S; Antonellis A; Burgess RW; Baets J
    Brain Commun; 2024; 6(2):fcae070. PubMed ID: 38495304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy.
    Abbott JA; Meyer-Schuman R; Lupo V; Feely S; Mademan I; Oprescu SN; Griffin LB; Alberti MA; Casasnovas C; Aharoni S; Basel-Vanagaite L; Züchner S; De Jonghe P; Baets J; Shy ME; Espinós C; Demeler B; Antonellis A; Francklyn C
    Hum Mutat; 2018 Mar; 39(3):415-432. PubMed ID: 29235198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
    Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
    Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in
    Kitani-Morii F; Noto YI
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drosophila as a platform to predict the pathogenicity of novel aminoacyl-tRNA synthetase mutations in CMT.
    Leitão-Gonçalves R; Ermanoska B; Jacobs A; De Vriendt E; Timmerman V; Lupski JR; Callaerts P; Jordanova A
    Amino Acids; 2012 May; 42(5):1661-8. PubMed ID: 21384131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.
    Storkebaum E
    Bioessays; 2016 Sep; 38(9):818-29. PubMed ID: 27352040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.
    Meyer-Schuman R; Antonellis A
    Hum Mol Genet; 2017 Oct; 26(R2):R114-R127. PubMed ID: 28633377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.